Milk consumption, galactose metabolism and ovarian cancer (Australia)

被引:48
作者
Webb, PM
Bain, CJ
Purdie, DM
Harvey, PWJ
Green, A
机构
[1] Univ Queensland, Sch Med, Dept Social & Prevent Med, Herston, Qld 4006, Australia
[2] Univ Queensland, Australian Ctr Int & Trop Hlth & Nutr, Nutr Program, St Lucia, Qld 4067, Australia
[3] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
关键词
Australia; galactose; lactose; ovarian neoplasms;
D O I
10.1023/A:1008891714412
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: It has been suggested that increased exposure to galactose, due to high consumption of dairy foods or reduced galactose metabolism, is associated with the development of ovarian cancer. We have investigated this in a large case-control study conducted in three Australian states between 1990 and 1993. Methods: Approximately 800 histologically-confirmed cases, 800 community controls and 300 controls recruited through breast-screening clinics completed dietary questionnaires. Approximately 100 cases and all breast-screening controls also provided a blood sample for analysis of galactose-1-phosphate-uridyltransferase (GALT), Results: Ovarian cancer risk was positively associated with increasing consumption of whole milk and other full-fat dairy foods, but was not associated with consumption of low-fat dairy foods and was inversely related to consumption of skimmed milk. There was no association between ovarian cancer and GALT except among women with abnormally low GALT who had a non-significant 2.5-fold increased risk of ovarian cancer. Conclusions: These data do not support the hypothesis that galactose plays a major role in the development of ovarian cancer and suggest that reported associations between milk consumption and ovarian cancer are due to the fat content of milk and not to lactose or galactose, An increased risk of ovarian cancer in women with abnormally low levels of GALT cannot, however, be ruled out.
引用
收藏
页码:637 / 644
页数:8
相关论文
共 27 条
[1]  
CRAMER DW, 1989, FERTIL STERIL, V51, P609
[3]  
CRAMER DW, 1989, LANCET, V2, P66, DOI 10.1016/S0140-6736(89)90313-9
[4]  
CRAMER DW, 1984, OBSTET GYNECOL, V63, P833
[5]  
CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717
[6]  
ENGLISH R, 1991, NUTR CONTENT AUSTR F
[7]   THE INFLUENCE OF LACTOSE CONSUMPTION ON THE ASSOCIATION OF ORAL-CONTRACEPTIVE USE AND OVARIAN-CANCER RISK [J].
HARLOW, BL ;
CRAMER, DW ;
GELLER, J ;
WILLETT, WC ;
BELL, DA ;
WELCH, WR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (05) :445-453
[8]   LACTOSE AND GALACTOSE INTAKE AND METABOLISM IN RELATION TO THE RISK OF EPITHELIAL OVARIAN-CANCER [J].
HERRINTON, LJ ;
WEISS, NS ;
BERESFORD, SAA ;
STANFORD, JL ;
WOLFLA, DM ;
FENG, ZD ;
SCOTT, CR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (05) :407-416
[9]   HYPERGONADOTROPIC HYPOGONADISM IN FEMALE PATIENTS WITH GALACTOSEMIA [J].
KAUFMAN, FR ;
KOGUT, MD ;
DONNELL, GN ;
GOEBELSMANN, U ;
MARCH, C ;
KOCH, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (17) :994-998
[10]   CORRELATION OF OVARIAN-FUNCTION WITH GALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE LEVELS IN GALACTOSEMIA [J].
KAUFMAN, FR ;
XU, YK ;
NG, WG ;
DONNELL, GN .
JOURNAL OF PEDIATRICS, 1988, 112 (05) :754-756